Marvell stock slips today as chips cool into year-end; MRVL traders eye Fed minutes and CES
30 December 2025
1 min read

Marvell stock slips today as chips cool into year-end; MRVL traders eye Fed minutes and CES

NEW YORK, December 29, 2025, 8:42 PM ET — Market closed

  • Marvell shares fell 0.6% to $85.76 as the chip sector turned mixed in late-year trading.
  • Nvidia and Broadcom slipped, while Intel rose after a filing showed Nvidia took a $5 billion stake.
  • Investors are watching Fed minutes, weekly jobless claims and Marvell’s CES-linked CEO appearance next.

Marvell Technology Inc (MRVL) shares fell 0.6% to $85.76 on Monday, with the Nasdaq-listed chipmaker trading between $84.21 and $86.09 as markets headed into the final trading days of the year.

Marvell supplies data infrastructure semiconductor solutions spanning the data center core to the network edge, and also develops chips tailored to specific customer designs for artificial intelligence and other networking-heavy workloads. 1

That mix leaves the stock sensitive to shifts in risk appetite around AI-linked hardware, especially when investors rebalance positions into year-end.

Semiconductors were mixed on the day. Nvidia fell about 1.2% and Broadcom slid 0.8%, while Intel rose 1.3%; the iShares Semiconductor ETF eased 0.2%.

Intel remained in focus after the company said in a filing that Nvidia had purchased Intel shares worth $5 billion, carrying out a transaction announced in September. 2

For Marvell, investors continue to treat the stock as part of the broader AI infrastructure trade, where moves often track sentiment on data-center buildouts and connectivity spending.

Before the next session, traders will be looking for signs that the late-year pullback in big tech is stabilizing. The Dow fell 0.51% on Monday, the S&P 500 lost 0.35% and the Nasdaq dropped 0.5%, according to Reuters. 3

Minutes from the Federal Reserve’s previous meeting and weekly jobless claims are also on the radar in what Reuters described as an otherwise data-light week. “It’ll turn out to be a buying opportunity,” said Hank Smith, director and head of investment strategy at Haverford Trust. 3

Marvell’s investor calendar lists a J.P. Morgan CES fireside chat with Chief Executive Matt Murphy on Jan. 6, but it does not yet show a date for the company’s next quarterly results. 4

Marvell is also promoting CES 2026 meetings in Las Vegas to showcase its copper and optical interconnect portfolio and CXL products; CXL, short for Compute Express Link, is a standard that helps servers connect processors and memory at high speed. Traders are also watching whether MRVL holds above $84, Monday’s low, and reclaims $86, the day’s high. 5

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Oklo stock drops nearly 4% after co-founders shift 15 million OKLO shares into trusts
Previous Story

Oklo stock drops nearly 4% after co-founders shift 15 million OKLO shares into trusts

MongoDB stock slides on “MongoBleed” security update as agencies warn of active exploitation
Next Story

MongoDB stock slides on “MongoBleed” security update as agencies warn of active exploitation

Go toTop